INSM - Company ID 0001104506
The table below shows INSMED Inc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$222.74M | -$262.09M | -$184.03M | -$146.30M | -$105.16M | -$128.28M |
| Capital expenditure | $3.48M | $10.07M | $4.68M | $3.40M | $1.70M | $1.18M |
| Investing cash flow | $265.52M | $80.41M | $295.32M | $41.60M | -$101.41M | -$1.18M |
| Dividends paid | - | - | - |
INSMED Inc reported operating cash flow of -$935.01M for fiscal year 2025. That is down 36.7% from -$683.88M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$146.71M (FY 2016) to -$935.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $29.51M | $29.00M | $3.02M | -$399.00K | $6.46M | $6.70M |